The concept of humanoid robot fell by more than 10%, Sanfeng Intelligent fell by more than 10%, Eft and Wuzhou Spring fell by more than 8%, and many stocks such as Beite Technology, Mingzhi Electric and Shuanglin fell by more than 5%.Guotai Junan expects Hong Kong stocks to fluctuate upward in an N-shaped pattern next year to explore domestic demand and improve investment opportunities. Chen Ximiao, chief analyst of Guotai Junan's overseas strategy, said that looking forward to 2025, the disturbance factors in the Hong Kong stock market from the external environment will continue, and the pace of interest rate cuts by the Federal Reserve under overseas inflation, policy restrictions in areas such as strong US dollar and tariffs, and game friction among big countries will continue. However, the domestic policy thinking is clear, economic expectations are expected to stabilize under the financial impetus, and the profitability of molecular enterprises will improve, and the industrial chain will be able to cope with it. She said that in 2025, the sensitivity of the Hong Kong stock market to external shocks is expected to decline, and more attention should be paid to returning to its own logic. For the trend of Hong Kong stocks in 2025, it is expected to be dominated by the upward pattern of N-shaped shocks, and there are many opportunities for flexibility during the stage. In 2025, we should still actively look for the structure, and focus on the barbell strategy to shift the weight of the two ends. We need to pay more attention to the configuration rhythm and pay attention to the repair opportunities of some domestic products.Qianyuan Medicine established a research and development company in Shanghai. According to the enterprise search APP, Qianyuan Medicine Research and Development (Shanghai) Co., Ltd. was recently established, with Mao Rengang as the legal representative and a registered capital of 10 million yuan. Its business scope includes: medical research and experimental development; Technical service, technical development, technical consultation, technical exchange, technology transfer and technology popularization. Enterprise investigation shows that the company is wholly owned by Qianyuan Medicine.
Li Dongsheng: The annual benefit of the landing application of TCL AI technology exceeds 540 million yuan. On December 11th, Li Dongsheng, the founder and chairman of TCL, said at the TCL Global Technology Innovation Conference that TCL promoted the landing application of AI technology in high-value scenes such as R&D and manufacturing through long-term development planning, with an annual benefit exceeding 540 million yuan. Yan Xiaolin, CTO of TCL Technology, CTO of TCL Huaxing and Dean of TCL Industrial Research Institute, said that AI has been used to improve the display quality, provide human-computer interaction ability, and also used in intelligent manufacturing. This 540 million yuan is the direct new benefit approved by the financial department and business department of BU (business department), excluding the unclear benefits such as image quality improvement and voice function. (CBN)In response to the Democratic Progressive Party authorities' deletion of the military academy curriculum on the island, the Taiwan Affairs Office spokeswoman Zhu Fenglian said: The Democratic Progressive Party authorities, out of the "Taiwan independence" nature, made great efforts to "de-China". Previously, they introduced the so-called "educational reform" policy and "Taiwan independence" curriculum, and this time they deleted the military academy curriculum on the island, so that military academy students could not see the history of the Anti-Japanese War and learn the wisdom of ancient China people. They tried to cut off the historical and cultural ties between the two sides of the Taiwan Straits in various ways, so as to deceive the people of Taiwan Province and deceive the young people of Taiwan Province into going to the battlefield for "Taiwan independence" and acting as cannon fodder for "Taiwan independence", which requires high vigilance. Facts have proved, and will continue to prove, that any "de-China" act can not separate the historical ties between the two sides of the strait and the blood ties between compatriots on both sides of the strait, let alone change the fact that Taiwan Province is a part of China. The perverse actions of the Democratic Progressive Party authorities are bound to be resolutely opposed by more and more Taiwan Province compatriots.Chief Cabinet Secretary Lin Fangzheng: We will continue to pay special attention to the developments in South Korea. The importance of Japan-ROK relations in the current strategic environment will not change.
How to "bargain" the price difference of Chinese patent medicines? According to CCTV news, the National Medical Insurance Bureau responded that the price of proprietary Chinese medicines is affected by many factors, including the price of medicinal materials, production technology and brand value, in view of the large price difference of proprietary Chinese medicines and the problem of "bargaining". Centralized purchasing effectively squeezes the inflated price of drugs and improves the efficiency of capital use through market-oriented bidding and price-volume linkage. At the same time, the medical insurance bureau will strengthen monitoring and supervision to ensure the quality and supply of drugs and protect the rights and interests of patients.China Merchants Bank applied for a trademark of a big model. According to the information of intellectual property rights, China Merchants Bank Co., Ltd. recently applied for the registration of the trademark of "YiZhao big model" and "YiZhao big model of China Merchants Bank". The international classification is advertising sales, website services and scientific instruments, and the current trademark status is awaiting substantive examination.Market news: Japan is considering levying a 4% corporate tax surcharge for national defense expenditure.
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide
12-14
Strategy guide 12-14
Strategy guide 12-14